[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100513432":3},{"organization":4,"armGroups":7,"interventions":13,"overallOfficials":10,"centralContacts":19,"locations":25,"responsibleParty":160,"collaborators":164,"id":180,"slug":10,"hasResults":181,"nctId":182,"briefTitle":183,"officialTitle":183,"acronym":10,"eligibilityCriteria":184,"healthyVolunteers":181,"sex":185,"minAge":186,"maxAge":187,"enrollmentInfo":188,"targetDuration":10,"studyType":191,"phases":10,"briefSummary":192,"conditions":193,"keywords":10,"overallStatus":196,"whyStopped":10,"lastUpdateSubmitDate":197,"lastUpdatePostDateStruct":198,"startDateStruct":201,"completionDateStruct":203,"leadSponsor":205,"locationsCount":206},{"fullName":5,"class":6},"Huashan Hospital","OTHER",[8],{"label":9,"type":10,"description":9,"interventionNames":11},"Chronic hepatitis B patients treated with nucleoside analogues or interferon",null,[12],"Drug: nucleoside analogues or interferon",[14],{"type":15,"name":16,"description":17,"armGroupLabels":18,"otherNames":10},"DRUG","nucleoside analogues or interferon","ETV、TDF、TAF、TAF、IFN-a-2b",[9],[20],{"name":21,"role":22,"phone":23,"phoneExt":10,"email":24},"Wenhong Zhang, MD","CONTACT","13801844344","zhangwenhong@fudan.edu.cn",[26,43,58,68,78,92,105,117,131,145],{"facility":27,"status":10,"city":28,"state":29,"zip":30,"country":31,"cosmosGeoPoint":32,"geoPoint":37,"contacts":38},"The First Affiliated Hospital of Anhui Medical University","Hefei","Anhui","230022","China",{"type":33,"coordinates":34},"Point",[35,36],117.28083,31.86389,{"lat":36,"lon":35},[39],{"name":40,"role":22,"phone":41,"phoneExt":10,"email":42},"Ying Ye","13856980361","yeying2@139.com",{"facility":44,"status":10,"city":45,"state":46,"zip":47,"country":31,"cosmosGeoPoint":48,"geoPoint":52,"contacts":53},"The First Affiliated Hospital of Fujian Medical University","Fuzhou","Fujian","350004",{"type":33,"coordinates":49},[50,51],119.30611,26.06139,{"lat":51,"lon":50},[54],{"name":55,"role":22,"phone":56,"phoneExt":10,"email":57},"Yuekai Hu, M.D.","13564579738","746896522@qq.com",{"facility":59,"status":10,"city":60,"state":61,"zip":62,"country":31,"cosmosGeoPoint":63,"geoPoint":67,"contacts":10},"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology","Wuhan","Hubei","430000",{"type":33,"coordinates":64},[65,66],114.26667,30.58333,{"lat":66,"lon":65},{"facility":69,"status":10,"city":70,"state":71,"zip":72,"country":31,"cosmosGeoPoint":73,"geoPoint":77,"contacts":10},"Jiangsu Province Hospital","Nanjing","Jiangsu","210000",{"type":33,"coordinates":74},[75,76],118.77778,32.06167,{"lat":76,"lon":75},{"facility":79,"status":10,"city":80,"state":71,"zip":81,"country":31,"cosmosGeoPoint":82,"geoPoint":86,"contacts":87},"the Affiliated Hosptial of Xuzhou Medical University","Xuzhou","221000",{"type":33,"coordinates":83},[84,85],117.28386,34.20442,{"lat":85,"lon":84},[88],{"name":89,"role":22,"phone":90,"phoneExt":10,"email":91},"Xuebing Yan, M.D.","15205215685","yxbxuzhou@126.com",{"facility":93,"status":10,"city":94,"state":95,"zip":10,"country":31,"cosmosGeoPoint":96,"geoPoint":100,"contacts":101},"Shandong Provincial Hospital of Shandong University","Jinan","Shandong",{"type":33,"coordinates":97},[98,99],116.99722,36.66833,{"lat":99,"lon":98},[102],{"name":103,"role":22,"phone":10,"phoneExt":10,"email":104},"Wanhua Ren","ganbingzx@163.com",{"facility":106,"status":10,"city":107,"state":108,"zip":10,"country":31,"cosmosGeoPoint":109,"geoPoint":113,"contacts":114},"The Third People's Hospital of Taiyuan","Taiyuan","Shanxi",{"type":33,"coordinates":110},[111,112],112.56028,37.86944,{"lat":112,"lon":111},[115],{"name":116,"role":22,"phone":10,"phoneExt":10,"email":10},"Ying Guo",{"facility":118,"status":10,"city":119,"state":108,"zip":120,"country":31,"cosmosGeoPoint":121,"geoPoint":125,"contacts":126},"First Affiliated Hospital Xi'an Jiaotong University","Xi’an","710061",{"type":33,"coordinates":122},[123,124],113.52486,35.99785,{"lat":124,"lon":123},[127],{"name":128,"role":22,"phone":129,"phoneExt":10,"email":130},"Yingli He, M.D.","18991232863","heyingli2000@mail.xjtu.edu.cn",{"facility":132,"status":10,"city":133,"state":134,"zip":135,"country":31,"cosmosGeoPoint":136,"geoPoint":140,"contacts":141},"The First People's Hospital Of YunNan","Kunming","Yunnan","650100",{"type":33,"coordinates":137},[138,139],102.71833,25.03889,{"lat":139,"lon":138},[142],{"name":143,"role":22,"phone":144,"phoneExt":10,"email":57},"Jiawei Geng, M.D.","13888757766",{"facility":5,"status":10,"city":146,"state":10,"zip":147,"country":31,"cosmosGeoPoint":148,"geoPoint":152,"contacts":153},"Shanghai","200040",{"type":33,"coordinates":149},[150,151],121.45806,31.22222,{"lat":151,"lon":150},[154,156],{"name":155,"role":22,"phone":23,"phoneExt":10,"email":24},"Wenhong Zhang, Professor",{"name":157,"role":22,"phone":158,"phoneExt":10,"email":159},"Feng Sun, doctor","15921403893","aaronsf1125@126.com",{"type":161,"investigatorFullName":162,"investigatorTitle":163,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"SPONSOR_INVESTIGATOR","Wen-hong Zhang","Director of Division ofInfectious Diseases Affiliation: Huashan Hospital",[165,168,169,171,173,174,176,177,178],{"name":166,"class":167},"Shandong Provincial Hospital","OTHER_GOV",{"name":118,"class":6},{"name":170,"class":6},"The Affiliated Hospital of Xuzhou Medical University",{"name":172,"class":6},"First Affiliated Hospital of Fujian Medical University",{"name":106,"class":6},{"name":175,"class":6},"The First People's Hospital of Yunnan",{"name":27,"class":6},{"name":59,"class":6},{"name":179,"class":6},"The First Affiliated Hospital with Nanjing Medical University","100513432",false,"NCT05965388","Predictive Value of HBV pgRNA on Long-term Outcomes in Hepatitis B Patients Treated With Antiviral Therapy","Inclusion Criteria:\n\n* CHB defined as positive hepatitis B surface antigen at least 6 months, or HBV-related histological changes within 1 year if HBsAg positive less than 6 months;\n* Age between 18-80 years, gender is not limited；\n* Patients with chronic hepatitis B who have been determined by clinicians to start, or have already taken the first-line treatment {including pegylated interferon \\[IFN\\] monotherapy, a potent nucleos(t)ide analogue \\[NA\\] monotherapy, two different potent NAs combination therapy, or NA plus IFN combination therapy;\n* Patient who reads and signs informed consent.\n\nExclusion Criteria:\n\n* Patients with malignancies other than hepatocellular carcinoma.","ALL","18 Years","80 Years",{"count":189,"type":190},5000,"ESTIMATED","OBSERVATIONAL","The goal of this prospective, exploratory, non-intervention, multi-center, real-world study is to investigate the predictive value of HBV pgRNA in the occurrence of long-term outcomes under antiviral therapy in patients with chronic hepatitis B.\n\nParticipants will take the necessary clinical examination and blood draw during the patient's treatment and follow-up, and all the treatment is determined by clinicians.",[194,195],"HBV","HCC","NOT_YET_RECRUITING","2023-07-20",{"date":199,"type":200},"2023-07-28","ACTUAL",{"date":202,"type":190},"2023-12-01",{"date":204,"type":190},"2029-02-01",{"name":162,"class":6},10]